...
首页> 外文期刊>Journal of Neurochemistry: Offical Journal of the International Society for Neurochemistry >Protein kinase C-mediated down-regulation of voltage-dependent sodium channels in adrenal chromaffin cells.
【24h】

Protein kinase C-mediated down-regulation of voltage-dependent sodium channels in adrenal chromaffin cells.

机译:蛋白激酶C介导的肾上腺嗜铬细胞中电压依赖性钠通道的下调。

获取原文
获取原文并翻译 | 示例

摘要

Treatment of cultured bovine adrenal chromaffin cells with 12-O-tetradecanoylphorbol 13-acetate (TPA), an activator of protein kinase C (PKC), decreased [3H]saxitoxin ([3H]STX) binding in a concentration (IC50 = 19 nM)- and time (t1/2 = 4.5 h)-dependent manner. TPA (100 nM for 15 h) lowered the Bmax of [3H]STX binding by 53% without altering the KD value. Phorbol 12,13-dibutyrate (PDBu) also reduced [3H]STX binding, whereas 4 alpha-TPA, an inactive analogue, had no effect. The inhibitory effect of TPA was abolished when H-7 (an inhibitor of PKC), but not H-89 (an inhibitor of cyclic AMP-dependent protein kinase), was included in the culture medium for 1 h before and during TPA treatment. Simultaneous treatment with TPA in combination with either actinomycin D or cycloheximide, an inhibitor of protein synthesis, nullified the effect of TPA. TPA treatment also attenuated veratridine-induced 22Na+ influx but did not alter the affinity of veratridine for Na channels as well as an allosteric potentiation ofveratridine-induced 22Na+ influx by brevetoxin. These results suggest that an activation of PKC down-regulates the density of Na channels without altering their pharmacological features; this down-regulation is mediated via the de novo synthesis of an as yet unidentified protein(s), rather than an immediate effect of Na channel phosphorylation.
机译:用12-O-十四烷酰佛波醇13-乙酸盐(TPA)(一种蛋白激酶C(PKC)的激活剂)处理培养的牛肾上腺嗜铬细胞,在浓度(IC50 = 19 nM)下降低了[3H] saxitoxin([3H] STX)的结合)和时间(t1 / 2 = 4.5 h)依赖的方式。 TPA(100 nM,15小时)在不改变KD值的情况下将[3H] STX结合的Bmax降低了53%。 Phorbol 12,13-dibutyrate(PDBu)也降低了[3H] STX的结合,而4α-TPA,一种无活性的类似物,则没有作用。在TPA处理之前和期间,在培养基中加入H-7(PKC抑制剂)而不是H-89(环状AMP依赖性蛋白激酶抑制剂)时,TPA的抑制作用消失。用TPA与放线菌素D或环己酰亚胺(一种蛋白质合成抑制剂)联合使用的同时治疗使TPA的作用无效。 TPA处理也减弱了维拉替丁诱导的22Na +流入,但没有改变维拉替啶对Na通道的亲和力,也没有改变藜芦酸引起的短立毒素的变构增效作用。这些结果表明,PKC的激活下调了Na通道的密度,而没有改变它们的药理特性。这种下调是通过尚未合成的蛋白质从头合成来介导的,而不是通过钠通道磷酸化的即时作用来介导的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号